Gynecomastia Treatment Market Research Report Information By Type (Drugs and Surgical Treatment), By Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL GYNECOMASTIA TREATMENT MARKET, BY TYPE

6.1. Overview

6.2. Drugs

6.3. Surgical Treatment

7. GLOBAL GYNECOMASTIA TREATMENT MARKET, BY APPLICATION

7.1. Overview

7.2. Hospital Pharmacies

7.3. Retail Pharmacies

7.4. Online Pharmacies

8. GLOBAL GYNECOMASTIA TREATMENT MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Gynecomastia Treatment Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Gynecomastia Treatment Market,

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. Allergan plc

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Pfizer Inc.

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Johnson & Johnson

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. MERCK & CO., INC.

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Novartis International AG

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Eli Lilly and Company

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. AbbVie Inc.

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Ipsen Pharma

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Endo Pharmaceuticals Inc.

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Sandoz International GmbH

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL GYNECOMASTIA TREATMENT MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL GYNECOMASTIA TREATMENT MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 US: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 8 US: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 9 CANADA: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 10 CANADA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 3 GERMANY: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 FRANCE: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 6 FRANCE: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 ITALY: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 8 ITALY: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 9 SPAIN: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 10 SPAIN: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 11 UK: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 12 UK: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 17 JAPAN: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 18 JAPAN: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 19 JAPAN: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 20 CHINA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 21 INDIA: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 22 INDIA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23 AUSTRALIA: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 24 AUSTRALIA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 33 AFRICA: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 34 AFRICA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: GYNECOMASTIA TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: GYNECOMASTIA TREATMENT MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL GYNECOMASTIA TREATMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL GYNECOMASTIA TREATMENT MARKET

FIGURE 4 GLOBAL GYNECOMASTIA TREATMENT MARKET, SHARE (%), BY TYPE, 2022

FIGURE 5 GLOBAL GYNECOMASTIA TREATMENT MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL GYNECOMASTIA TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: GYNECOMASTIA TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: GYNECOMASTIA TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: GYNECOMASTIA TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: GYNECOMASTIA TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL GYNECOMASTIA TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 ALLERGAN PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 ALLERGAN PLC: SWOT ANALYSIS

FIGURE 14 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 PFIZER INC.: SWOT ANALYSIS

FIGURE 16 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 JOHNSON & JOHNSON: SWOT ANALYSIS

FIGURE 18 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 MERCK & CO., INC.: SWOT ANALYSIS

FIGURE 20 NOVARTIS INTERNATIONAL AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 NOVARTIS INTERNATIONAL AG: SWOT ANALYSIS

FIGURE 22 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 ELI LILLY AND COMPANY: SWOT ANALYSIS

FIGURE 24 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 ABBVIE INC.: SWOT ANALYSIS

FIGURE 26 IPSEN PHARMA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 IPSEN PHARMA: SWOT ANALYSIS

FIGURE 28 ENDO PHARMACEUTICALS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ENDO PHARMACEUTICALS INC.: SWOT ANALYSIS

FIGURE 30 SANDOZ INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 SANDOZ INTERNATIONAL GMBH: SWOT ANALYSIS